What is the current Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market size?

The Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029) Read More

Who are the key players in Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market?

Pfizer Inc. , Johnson & Johnson , Bayer AG, Sanofi S.A. and GlaxoSmithKline plc are the major companies operating in the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market. Read More

Which is the fastest growing region in Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market?

In 2024, the North America accounts for the largest market share in Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market. Read More

What years does this Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market cover?

The report covers the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Non-Steroidal Anti-Inflammatory Drugs - NSAIDs Market

Non-Steroidal Anti-Inflammatory Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market is Segmented by Route of Administration (Oral and Parenteral), Application (Arthritis, Migraine, Ophthalmic Diseases, and Other Applications), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others Distribution Channels), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Overview

The NSAIDs market is moderately competitive, with several players across the globe. In terms of market share, few of the major players currently dominate the market. With the increase in research and development activity, many regional players are expected to contribute to the NSAIDs market over the forecast period. Some of the key players in the market are Pfizer Inc., GlaxoSmithKline Plc, Johnson and Johnson, Bayer AG, Sanofi S.A., Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd, Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Assertio Therapeutics, Inc., and others.